Wall Street analysts predict that Imperva Inc (NYSE:IMPV) will announce sales of $82.29 million for the current quarter, according to Zacks. Seven analysts have made estimates for Imperva’s earnings, with estimates ranging from $82.01 million to $82.98 million. Imperva reported sales of $68.41 million during the same quarter last year, which would suggest a positive year over year growth rate of 20.3%. The firm is scheduled to announce its next quarterly earnings report on Thursday, November 2nd.

According to Zacks, analysts expect that Imperva will report full year sales of $82.29 million for the current fiscal year, with estimates ranging from $320.90 million to $322.76 million. For the next year, analysts forecast that the company will report sales of $379.23 million per share, with estimates ranging from $369.00 million to $386.30 million. Zacks Investment Research’s sales averages are an average based on a survey of analysts that follow Imperva.

Imperva (NYSE:IMPV) last issued its quarterly earnings results on Thursday, July 27th. The software maker reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.05 by ($0.15). Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The business had revenue of $74.44 million during the quarter, compared to the consensus estimate of $74.30 million. During the same quarter last year, the firm posted ($0.23) earnings per share. Imperva’s revenue was up 28.6% compared to the same quarter last year.

Several equities analysts recently issued reports on IMPV shares. Evercore ISI set a $56.00 price target on Imperva and gave the company a “buy” rating in a report on Thursday, August 10th. BidaskClub lowered Imperva from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 5th. Monness Crespi & Hardt raised their price target on Imperva from $55.00 to $57.00 and gave the stock a “buy” rating in a research report on Friday, July 28th. Piper Jaffray Companies set a $58.00 price target on Imperva and gave the stock a “buy” rating in a research report on Monday, August 28th. Finally, Stifel Nicolaus reissued a “hold” rating and issued a $47.00 target price on shares of Imperva in a research report on Friday, July 14th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and twelve have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $52.78.

COPYRIGHT VIOLATION NOTICE: “Zacks: Analysts Anticipate Imperva Inc (IMPV) Will Post Quarterly Sales of $82.29 Million” was posted by Watch List News and is owned by of Watch List News. If you are reading this article on another website, it was illegally copied and republished in violation of international trademark and copyright laws. The original version of this article can be read at https://www.watchlistnews.com/zacks-analysts-anticipate-imperva-inc-impv-will-post-quarterly-sales-of-82-29-million/1609699.html.

In related news, Director Anthony J. Bettencourt sold 99,598 shares of the company’s stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the sale, the director now owns 99,598 shares in the company, valued at approximately $4,341,476.82. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 2.20% of the company’s stock.

Several institutional investors have recently made changes to their positions in IMPV. Wells Fargo & Company MN boosted its holdings in Imperva by 33.2% in the first quarter. Wells Fargo & Company MN now owns 102,511 shares of the software maker’s stock worth $4,208,000 after acquiring an additional 25,530 shares in the last quarter. US Bancorp DE boosted its holdings in Imperva by 142.3% in the first quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock worth $221,000 after acquiring an additional 3,163 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in Imperva by 1.9% in the first quarter. Bank of New York Mellon Corp now owns 125,398 shares of the software maker’s stock worth $5,148,000 after acquiring an additional 2,295 shares in the last quarter. Comerica Bank bought a new position in Imperva in the first quarter worth approximately $850,000. Finally, UBS Asset Management Americas Inc. boosted its holdings in Imperva by 107.3% in the first quarter. UBS Asset Management Americas Inc. now owns 13,889 shares of the software maker’s stock worth $570,000 after acquiring an additional 7,189 shares in the last quarter. Institutional investors own 92.72% of the company’s stock.

Shares of Imperva (NYSE:IMPV) opened at 43.75 on Thursday. The company’s market capitalization is $1.48 billion. Imperva has a 12 month low of $34.40 and a 12 month high of $57.24. The firm has a 50-day moving average of $44.11 and a 200 day moving average of $45.69.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Get a free copy of the Zacks research report on Imperva (IMPV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.